Compounds and nutrients that support sustained energy production, mitochondrial function, and physical vitality.
28 itemsA focused review of how CoQ10 underpins cellular energy, how aging and statins intersect with CoQ10 biology, and where clinical research signals potential benefits—plus forms and PQQ as a complement.
Hyponatremia in endurance exercise explained: why it happens, who’s at risk, and what research suggests about sodium-containing drinks, ORS science, and traditional salty foods—without one-size-fits-all dosing.
Is burnout really “adrenal fatigue”? Evidence suggests burnout reflects HPA axis dysregulation and altered cortisol rhythms—not failing adrenal glands. Learn what studies show and where adaptogens like ashwagandha and rhodiola may fit, plus Ayurvedic/TCM perspectives.
Thinking about an ice bath after lifting? Research suggests regular, immediate post-lift cold exposure may blunt muscle and strength gains, even as it can reduce soreness and help short-term recovery.
Ferritin can reveal iron deficiency even when hemoglobin is normal. Learn how low ferritin relates to fatigue, brain fog, and restless legs; who may benefit from testing; and how diet, cooking methods, and traditional practices fit in—plus why iron overload risk means testing matters.
Focused review of BPC‑157 for tendon and ligament repair: mechanisms, animal data, clinical trial status, safety, and why athletes are interested—emphasizing the gap between preclinical promise and human evidence.
A focused, evidence‑based look at L‑glutamine for exercise‑induced gut permeability—what the research shows, how it ties to the gut–muscle axis, and where traditional practices like bone broth fit.
A focused, evidence-based look at how beta-alanine may enhance 1–10 minute high-intensity efforts by increasing muscle carnosine and buffering acidity, with side effects, research protocols, ISSN guidance, and comparisons to other ergogenic aids.
Cold plunges are popular, but what do they really do for recovery? This evidence-based guide parses the research on ice baths, cryotherapy, and contrast therapy—covering soreness, performance, cold shock proteins, brown fat, and when cold may blunt training adaptations—alongside Nordic traditions and the Wim Hof Method.
Beta‑alanine increases muscle carnosine to buffer acidity and may yield small but meaningful gains in 1–10 minute high‑intensity efforts. Here’s what meta‑analyses, RCTs, and the ISSN position stand say—plus side effects, strategies, and how it compares to creatine, caffeine, and bicarbonate.
A research-grounded review of CoQ10’s role in mitochondrial energy, aging, statin-related depletion, heart failure, migraines, fertility, and the ubiquinone vs ubiquinol debate—plus how PQQ may complement CoQ10.
Glutamine sits at the crossroads of muscle, gut, and immune function. Here’s what research says about its role in athletic recovery, gut barrier integrity, immune health in athletes, burn/trauma care, and IBS—with a bridge to the traditional bone broth perspective.
BPC‑157 is a gut‑derived peptide that may accelerate tendon, ligament, and muscle healing in animal models, but it remains unapproved, prohibited in sport, and unproven in human trials.
CoQ10 powers mitochondrial energy production and may support healthy aging. This evidence-based guide reviews age-related decline, statin effects, heart failure (Q-SYMBIO), migraine prevention, fertility research, bioavailability of ubiquinone vs. ubiquinol, and PQQ as a complementary compound.
Iron deficiency can cause fatigue, brain fog, and restless legs even without anemia. Learn why ferritin often outperforms hemoglobin, how diet and traditional practices influence absorption, who may benefit from testing, and why too much iron can be harmful.
Electrolytes matter—but not always the way sports drink ads suggest. This evidence-based guide covers sodium, potassium, and magnesium balance, hyponatremia risks, sweat variability, oral rehydration science, and how traditional options like coconut water and broth can fit into smart hydration for performance.
Type I, II, III — not all collagen is the same. Which forms actually work, optimal dosing, and how to pair collagen with vitamin C for absorption.
The most studied supplement in history does far more than build muscle. A deep dive into creatine for cognition, energy, and healthy aging.
Inside the science of nicotinamide mononucleotide, NAD+ precursors, and why researchers believe they may slow biological aging.
Everything you need to know about healing peptides — mechanisms, dosing protocols, stacking strategies, and what the research actually shows.
Creatine monohydrate is the most extensively studied dietary supplement in sports nutrition history, with over 500 peer-reviewed studies supporting its efficacy. It is a naturally occurring compound synthesized from three amino acids — arginine, glycine, and methionine — primarily in the liver, kidneys, and pancreas. The molecule functions by donating a phosphate group to regenerate ATP (adenosine triphosphate), the fundamental energy currency of every cell. When stored in muscles as phosphocreatine, it enables rapid ATP recycling during high-intensity, short-duration activities like sprinting and resistance training. Beyond athletic performance, emerging research highlights creatine's role in cognitive function, neuroprotection, and healthy aging. The brain is metabolically demanding, consuming roughly 20% of the body's energy at rest, and creatine supplementation appears to support cognitive performance particularly under conditions of sleep deprivation or mental fatigue.
Lion's Mane (Hericium erinaceus) is an edible medicinal mushroom with a distinctive cascading white appearance resembling a lion's mane. It has been used in traditional Chinese and Japanese medicine for centuries, primarily for digestive and neurological support. What sets Lion's Mane apart from other medicinal mushrooms is its unique ability to stimulate the production of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) through its bioactive compounds — hericenones (found in the fruiting body) and erinacines (found in the mycelium). These neurotrophins are critical for the growth, maintenance, and survival of neurons. Human clinical trials, while still limited in number, have shown promising results for cognitive function in older adults with mild cognitive impairment, as well as reductions in anxiety and depression symptoms. The mechanism appears to involve both direct neurotrophic effects and anti-inflammatory modulation in the central nervous system.
An amino acid found primarily in green tea that promotes relaxation without drowsiness and supports focused calm.
A precursor to glutathione, the bodys master antioxidant, used for respiratory health, liver support, and antioxidant defense.
Chronic Fatigue Syndrome, also termed Myalgic Encephalomyelitis (ME/CFS), is a complex, multi-system illness characterized by profound fatigue, marked reduction in pre-illness activity, non-restorative sleep, cognitive difficulties, orthostatic intolerance, and especially post-exertional malaise (PEM)—a delayed exacerbation of symptoms after physical, cognitive, or emotional exertion. PEM is now widely recognized as the cardinal feature of ME/CFS and a key differentiator from primary depression or simple deconditioning. Onset can be sudden (often after an infection) or gradual, and severity ranges from mild functional limitation to complete home- or bed-bound states. The condition affects quality of life at levels comparable to other serious chronic diseases, yet no single biomarker or curative therapy has been validated to date. Western medicine conceptualizes ME/CFS as a neuroimmune and metabolic disorder evaluated by clinical criteria and exclusion of alternative explanations. Multiple diagnostic frameworks exist, including the Fukuda (1994) criteria, the Canadian Consensus Criteria (2003), and the Institute of Medicine/National Academy of Medicine criteria (2015; Systemic Exertion Intolerance Disease, SEID). All emphasize substantial impairment and persistent fatigue not alleviated by rest, with the IOM/SEID requiring PEM, unrefreshing sleep, and either cognitive impairment or orthostatic intolerance. Research has described autonomic dysregulation, immune activation and heterogeneously altered cytokines, small-fiber neuropathy in some patients, cerebral hypoperfusion, reduced aerobic capacity with abnormal repeat cardiopulmonary exercise testing, and gastrointestinal dysbiosis. Immune-modulating therapies such as rituximab that showed early promise have failed in larger, rigorous trials. Microbiome work reveals compositional and functional differences and links to symptom severity, but interventional evidence remains preliminary. Management in contemporary, (e
Chronic Fatigue Syndrome, also called Myalgic Encephalomyelitis (CFS/ME), is a complex, multi-system condition characterized by profound fatigue that is not improved by rest and is worsened by exertion. A defining, cardinal feature is post-exertional malaise (PEM): a delayed worsening of symptoms—fatigue, cognitive dysfunction (“brain fog”), pain, sleep disturbance, autonomic and flu-like symptoms—after physical, cognitive, or emotional stress. Many patients experience orthostatic intolerance (e.g., POTS or neurally mediated hypotension), unrefreshing sleep, and cognitive impairment, among other symptoms. The illness exists on a spectrum of severity, from reduced activity to housebound or bedbound states. There is currently no single diagnostic test or disease-modifying cure; care focuses on accurate diagnosis, energy management (pacing), treating comorbidities, and mitigating symptom burden. Western frameworks emphasize standardized diagnostic criteria and symptom-based management, with growing recognition of immune, autonomic, and metabolic abnormalities. The Fukuda criteria (1994) historically informed research but underweighted PEM. The Canadian Consensus Criteria (2003) and the U.S. Institute of Medicine/National Academy of Medicine report (2015) elevated PEM as essential and reframed the condition (SEID—systemic exertion intolerance disease). In 2021, the UK’s NICE guideline NG206 recognized PEM as central, reversed prior endorsements of graded exercise therapy (GET), and advised against any program that pushes patients to increase activity beyond their energy envelope. Evidence for GET was driven largely by the PACE trial (2011), which later drew substantial methodological criticism and reanalysis indicating far more limited benefits than originally claimed. Current best practice centers on pacing—patient-led activity regulation to prevent PEM. Pharmacologic strategies are symptom-targeted. Sleep aids (e.g., low-dose tricyclics like amitriptyline or doxepin
Fibromyalgia (FM) and Chronic Fatigue Syndrome / Myalgic Encephalomyelitis (CFS/ME) are chronic, often disabling conditions with substantial symptomatic overlap yet distinct diagnostic anchors. FM ...
Multiple sclerosis (MS) is a chronic, immune-mediated demyelinating disease of the central nervous system. Fatigue—often described as an overwhelming lack of physical and/or mental energy—is among ...
